Golden State Equity Partners - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 61 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2022. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Golden State Equity Partners ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q2 2023$22,154
+7.7%
19,7800.0%0.01%
-45.5%
Q1 2023$20,571
-71.4%
19,780
-36.9%
0.01%
-69.4%
Q1 2022$72,000
-14.3%
31,327
+2.6%
0.04%
-14.3%
Q4 2021$84,00030,5270.04%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,462,500$11,993,0006.16%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$6,410,0002.56%
AJU IB Investment Co., Ltd. 293,555$1,430,0000.82%
RTW INVESTMENTS, LP 4,206,765$20,487,0000.31%
Carmignac Gestion 3,419,877$16,655,0000.19%
EAM Investors, LLC 247,561$1,206,0000.19%
Curi Wealth Management, LLC 25,000$121,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,542,0000.03%
TWO SIGMA ADVISERS, LP 990,000$4,821,0000.01%
CAXTON ASSOCIATES LP 24,677$120,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders